Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 07.05.2026 GNOV LN IE000OJ31JQ4 1,050,002.00 USD 38,152,791.65 36.336  ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Lumentum Holdings Inc. ("Lumentum") today announced that company management is currently scheduled participate in the following investor events: Event: 21st Annual Needham Technology, Media & Consumer Conference (Virtual) Date: Thursday, May 14, 2026 Meeting Availability: 10:15 a.m. – 3:40 p.m. Eastern Time   Event: 2026 J.P. Morgan Global Technology, Media and Communications Conference, Boston Date: Monday, May 18, 2026 Webcast Link: https://jpmorgan.meta...

NEW YORK--(BUSINESS WIRE)--Predictive intelligence company, Anadyr Horizon, today announced the launch of Red Horizon, a new premium subscription tier that gives organizations unlimited access to its North Star platform – an ASI-powered simulation system designed to model how real-world decisions cascade into geopolitical crises. Delivered through the North Star platform, Red Horizon provides continuous access to agent-based simulations powered by Agentic Systems Intelligence (ASI); custom scen...

KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSEAMERICAN: FLYX), a leading provider of premium private jet experiences, announced it will release first quarter 2026 financial results through a Form 10-Q to be filed with the Securities and Exchange Commission (SEC) following the markets close on May 11, 2026. When filed, the Form 10-Q can be found at https://ir.flyexclusive.com/sec-filings or at www.sec.gov. When filed, a supplemental presentation of first quarter results can also be fou...

FORT WORTH, Texas--(BUSINESS WIRE)--Presidio Production Company (NYSE: FTW) (“Presidio” or the “Company”), a yield-focused, differentiated oil and gas operator in the United States focused on the acquisition and optimization of producing oil and natural gas wells, without drilling, today announced the execution of definitive purchase and sale agreements to acquire the Canyon Creek assets for approximately $83 million (the “Transaction”) from companies controlled by Vortus Investments and additi...

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the previously announced tender offer to acquire all outstanding shares of Assertio to May 14, 2026. As previously announced on May 4, 2026, Assertio has entered into an amended and restated merger agreement (the “Garda Agreement”) to be acquired by Garda for $21.80 per shar...

PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology and microbial therapeutics company, today announced a new investment from Gates Foundation. Through this investment, Kanvas will develop the world’s first fully synthetic microbiome replacement product designed to treat and prevent maternal environmental enteric dysfunction (EED), a major contributor to maternal undernutrition, low infant birthweight and heightened neonatal health risk. Using global metagenomic d...